E-LIB Suche - Ergebnisse für: Pfreundschuh, M

1

Safety and feasibility of electrical muscle stimulation in ..:

Bewarder, M. ; Klostermann, A. ; Ahlgrimm, M....
Supportive Care in Cancer. 27 (2018) 3 - p. 1013-1020 , 2018

Link: https://doi.org/10.1007/..

2

ESMO Consensus Conference on malignant lymphoma: management..:

Hutchings, M. ; Ladetto, M. ; Buske, C....
Annals of Oncology. 29 (2018) 8 - p. 1687-1700 , 2018

Link: https://doi.org/10.1093/..

3

Outcome of elderly patients with diffuse large B-cell lymph..:

Kühnl, A. ; Cunningham, D. ; Counsell, N....
Annals of Oncology. 28 (2017) 7 - p. 1540-1546 , 2017

Link: https://doi.org/10.1093/..

4

ANTI‐INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE..:

Murawski, N. ; Amam, J. ; Altmann, B....
Hematological Oncology. 35 (2017) S2 - p. 200-201 , 2017

Link: https://doi.org/10.1002/..

5

RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAF..:

Lugtenburg, P.J. ; Avivi, I. ; Berenschot, H.W....
Hematological Oncology. 35 (2017) S2 - p. 185-186 , 2017

Link: https://doi.org/10.1002/..

6

Obesity negatively impacts outcome in elderly female patien..:

Hohloch, K. ; Altmann, B. ; Pfreundschuh, M....
British Journal of Haematology. 180 (2017) 2 - p. 236-245 , 2017

Link: https://doi.org/10.1111/..

7

Bortezomib before and after high-dose therapy in myeloma: l..:

Goldschmidt, H ; Lokhorst, H M ; Mai, E K...
Leukemia. 32 (2017) 2 - p. 383-390 , 2017

Link: https://doi.org/10.1038/..

8

RADIOTHERAPY TO BULKY DISEASE PET‐NEGATIVE AFTER IMMUNOCHEM..:

Pfreundschuh, M. ; Christofyllakis, K. ; Altmann, B....
Hematological Oncology. 35 (2017) S2 - p. 129-130 , 2017

Link: https://doi.org/10.1002/..

9

High-dose chemotherapy with autologous haematopoietic stem ..:

Kasenda, B ; Ihorst, G ; Schroers, R...
Leukemia. 31 (2017) 12 - p. 2623-2629 , 2017

Link: https://doi.org/10.1038/..

10

ESMO consensus conference on malignant lymphoma: general pe..:

Ladetto, M. ; Buske, C. ; Hutchings, M....
Annals of Oncology. 27 (2016) 12 - p. 2149-2160 , 2016

Link: https://doi.org/10.1093/..

11

Aktuelle Therapiestrategien beim diffusen großzelligen B‑Ze..:

Pfreundschuh, M.
Der Internist. 57 (2016) 3 - p. 214-221 , 2016

Link: https://doi.org/10.1007/..

12

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practi..:

Tilly, H. ; Gomes da Silva, M. ; Vitolo, U....
Annals of Oncology. 26 (2015) - p. v116-v125 , 2015

Link: https://doi.org/10.1093/..

13

CHO(E)P-14 followed by alemtuzumab consolidation in untreat..:

for the German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) ; Binder, C. ; Ziepert, M....
Annals of Hematology. 92 (2013) 11 - p. 1521-1528 , 2013

Link: https://doi.org/10.1007/..

14

Comparison and modelling of pegylated or unpegylated G-CSF ..:

for the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) ; Zeynalova, S. ; Ziepert, M....
Annals of Hematology. 92 (2013) 12 - p. 1641-1652 , 2013

Link: https://doi.org/10.1007/..

15

Therapiestrategien beim diffusen großzelligen B-Zell-Lympho:

Held, G. ; Murawski, N. ; Pfreundschuh, M.
Der Onkologe. 17 (2011) 9 - p. 789-798 , 2011

Link: https://doi.org/10.1007/..